Crossmark

Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)—a randomized trial

Crossref DOI link: https://doi.org/10.1038/s41598-023-34008-y

Published Online: 2023-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Zhiming

Meng, Peina

Guo, Yajie

You, Wei

Wu, Xiangqi

Ye, Fei
Funding

Funding for this research was provided by:

Cardiocare Sponsored (CS) Optimized Antithrombotic Research Fund (BJUHFCSOARF201801-13)
License Information

Text and Data Mining valid from 2023-04-24

Version of Record valid from 2023-04-24
More Information

Article History

Received: 22 November 2022

Accepted: 22 April 2023

First Online: 24 April 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below